These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12891567)

  • 1. Iron and HFE mutations in nonalcoholic steatohepatitis: innocent bystanders or accessories to the crime?
    Bhattacharya R; Kowdley KV
    Gastroenterology; 2003 Aug; 125(2):615-6; discussion 617. PubMed ID: 12891567
    [No Abstract]   [Full Text] [Related]  

  • 2. HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.
    Valenti L; Fracanzani AL; Bugianesi E; Dongiovanni P; Galmozzi E; Vanni E; Canavesi E; Lattuada E; Roviaro G; Marchesini G; Fargion S
    Gastroenterology; 2010 Mar; 138(3):905-12. PubMed ID: 19931264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of iron in nonalcoholic fatty liver disease: the story continues.
    Kowdley KV
    Gastroenterology; 2010 Mar; 138(3):817-9. PubMed ID: 20116466
    [No Abstract]   [Full Text] [Related]  

  • 4. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.
    Loria P; Lonardo A; Carulli N
    Hepatology; 2004 Jun; 39(6):1748; author reply 1749. PubMed ID: 15185321
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence of the hemochromatosis gene mutation in patients with nonalcoholic steatohepatitis and correlation with degree of liver fibrosis.
    Zamin I; Mattos AA; Mattos AZ; Migon E; Bica C; Alexandre CO
    Arq Gastroenterol; 2006; 43(3):224-8. PubMed ID: 17160239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.
    Chitturi S; Weltman M; Farrell GC; McDonald D; Kench J; Liddle C; Samarasinghe D; Lin R; Abeygunasekera S; George J
    Hepatology; 2002 Jul; 36(1):142-9. PubMed ID: 12085358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered lipid metabolism in Hfe-knockout mice promotes severe NAFLD and early fibrosis.
    Tan TC; Crawford DH; Jaskowski LA; Murphy TM; Heritage ML; Subramaniam VN; Clouston AD; Anderson GJ; Fletcher LM
    Am J Physiol Gastrointest Liver Physiol; 2011 Nov; 301(5):G865-76. PubMed ID: 21817060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HFE mutations in nonalcoholic fatty liver disease.
    Valenti L; Dongiovanni P; Fracanzani AL; Fargion S
    Hepatology; 2008 May; 47(5):1794-5; author reply 1795-6. PubMed ID: 18438784
    [No Abstract]   [Full Text] [Related]  

  • 9. HFE mutations analysis of Turkish patients with nonalcoholic steatohepatitis.
    Simsek H; Balaban YH; Sümer H; Yilmaz E; Tatar G
    Dig Dis Sci; 2006 Oct; 51(10):1723-4. PubMed ID: 16964543
    [No Abstract]   [Full Text] [Related]  

  • 10. Iron as a co-morbid factor in nonhemochromatotic liver disease.
    Bonkovsky HL; Lambrecht RW; Shan Y
    Alcohol; 2003 Jun; 30(2):137-44. PubMed ID: 12957298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of evidence for the pathogenic role of iron and HFE gene mutations in Brazilian patients with nonalcoholic steatohepatitis.
    Deguti MM; Sipahi AM; Gayotto LC; Palácios SA; Bittencourt PL; Goldberg AC; Laudanna AA; Carrilho FJ; Cançado EL
    Braz J Med Biol Res; 2003 Jun; 36(6):739-45. PubMed ID: 12792703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease and HFE gene mutations: a Polish study.
    Raszeja-Wyszomirska J; Kurzawski G; Lawniczak M; Miezynska-Kurtycz J; Lubinski J
    World J Gastroenterol; 2010 May; 16(20):2531-6. PubMed ID: 20503453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Non-alcoholic fatty liver disease, serum iron indexes and iron concentration in the liver].
    Fernández Salazar LI; Aller de la Fuente R; Velayos Jiménez B; González Hernández JM
    Gastroenterol Hepatol; 2005; 28(6):364. PubMed ID: 15989823
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis C, iron status, and disease severity: relationship with HFE mutations.
    Tung BY; Emond MJ; Bronner MP; Raaka SD; Cotler SJ; Kowdley KV
    Gastroenterology; 2003 Feb; 124(2):318-26. PubMed ID: 12557137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.
    Bugianesi E; Manzini P; D'Antico S; Vanni E; Longo F; Leone N; Massarenti P; Piga A; Marchesini G; Rizzetto M
    Hepatology; 2004 Jan; 39(1):179-87. PubMed ID: 14752836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The HFE gene heterozygosis H63D: a cofactor for liver damage in patients with steatohepatitis? Epidemiological and clinical considerations.
    Neri S; Pulvirenti D; Signorelli S; Ignaccolo L; Tsami A; Mauceri B; Misseri M; Interlandi D; Cutuli N; Castellino P
    Intern Med J; 2008 Apr; 38(4):254-8. PubMed ID: 17916170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron, HFE mutations, and hepatocellular carcinoma: is hepatic iron a carcinogen?
    Ioannou GN; Kowdley KV
    Clin Gastroenterol Hepatol; 2003 Jul; 1(4):246-8. PubMed ID: 15017663
    [No Abstract]   [Full Text] [Related]  

  • 18. [The prevalence of peripheral iron overload and the presence of HFE gene (H63D) mutation among the Korean patients with nonalcoholic fatty liver disease].
    Lee D; Jeong SH; Lee M; Cho YA; Kim JW; Park Y; Hwang JH; Kim NY; Lee DH
    Korean J Hepatol; 2007 Jun; 13(2):174-84. PubMed ID: 17585191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of HFE mutations and relation to serum iron status in patients with chronic hepatitis C and patients with nonalcoholic fatty liver disease in Taiwan.
    Lin TJ; Lin CL; Wang CS; Liu SO; Liao LY
    World J Gastroenterol; 2005 Jul; 11(25):3905-8. PubMed ID: 15991291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron, the HFE gene, and hepatitis C.
    Eisenbach C; Gehrke SG; Stremmel W
    Clin Liver Dis; 2004 Nov; 8(4):775-85, vii-viii. PubMed ID: 15464655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.